Arcidiacono D, Dedja A, Giacometti C, Fassan M, Nucci D, Francia S, Fabris F, Zaramella A, Gallagher EJ, Cassaro M, Rugge M, LeRoith D, Alberti A, Realdon S (2018) Hyperinsulinemia promotes esophageal Cancer Development in a surgically-Induced Duodeno-Esophageal Reflux Murine Model. Int J Mol Sci 19. https://doi.org/10.3390/ijms19041198

Bala C, Gheorghe-Fronea O, Pop D, Pop C, Caloian B, Comsa H, Bozan C, Matei C, Dorobantu M (2019) The Association between six surrogate insulin resistance indexes and hypertension: a Population-based study. Metab Syndr Relat Disord 17:328–333. https://doi.org/10.1089/met.2018.0122

Article  CAS  PubMed  Google Scholar 

Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, Viveros-Ruiz T, Cruz-Bautista I, Romo-Romo A, Sánchez-Lázaro D, Meza-Oviedo D, Vargas-Vázquez A, Campos OA, Del Sevilla-González MR, Martagón AJ, Hernández LM, Mehta R, Caballeros-Barragán CR, Aguilar-Salinas CA (2018) METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol 178:533–544. https://doi.org/10.1530/EJE-17-0883

Article  CAS  PubMed  Google Scholar 

Budiyani L, Purnamasari D, Simadibrata M, Abdullah M (2018) Insulin resistance in gastroesophageal reflux disease. Acta Med Indones 50:336–342

PubMed  Google Scholar 

Cheng W, Kong F, Chen S (2022) Comparison of the predictive value of four insulin resistance surrogates for the prevalence of hypertension: a population-based study. Diabetol Metab Syndr 14:137. https://doi.org/10.1186/s13098-022-00907-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Creemers A, Ebbing EA, Hooijer GKJ, Stap L, Jibodh-Mulder RA, Gisbertz SS, van Berge Henegouwen, Mark I, van Montfoort ML, Hulshof, Maarten CCM, Krishnadath KK, van Oijen, Martijn GH, Bijlsma MF, Meijer SL, van Laarhoven, Hanneke WM (2018) The dynamics of HER2 status in esophageal adenocarcinoma. Oncotarget 9:26787–26799. https://doi.org/10.18632/oncotarget.25507

Article  PubMed  PubMed Central  Google Scholar 

Er L-K, Wu S, Chou H-H, Hsu L-A, Teng M-S, Sun Y-C, Ko Y-L (2016) Triglyceride glucose-body Mass Index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals. PLoS ONE 11:e0149731. https://doi.org/10.1371/journal.pone.0149731

Article  CAS  PubMed  PubMed Central  Google Scholar 

Farahani H, Mahmoudi T, Asadi A, Nobakht H, Dabiri R, Hamta A (2020) Insulin resistance and colorectal Cancer risk: the role of elevated plasma resistin levels. J Gastrointest Cancer 51:478–483. https://doi.org/10.1007/s12029-019-00260-7

Article  CAS  PubMed  Google Scholar 

Gluvic Z, Zaric B, Resanovic I, Obradovic M, Mitrovic A, Radak D, Isenovic ER (2017) Link between metabolic syndrome and insulin resistance. Curr Vasc Pharmacol 15:30–39. https://doi.org/10.2174/1570161114666161007164510

Article  CAS  PubMed  Google Scholar 

Grieb BC, Agarwal R (2021) HER2-Directed Therapy in Advanced gastric and gastroesophageal adenocarcinoma: triumphs and troubles. Curr Treat Options Oncol 22:88. https://doi.org/10.1007/s11864-021-00884-7

Article  PubMed  PubMed Central  Google Scholar 

Hu Y, Bandla S, Godfrey TE, Tan D, Luketich JD, Pennathur A, Qiu X, Hicks DG, Peters JH, Zhou Z (2011) HER2 amplification, overexpression and score criteria in esophageal adenocarcinoma. Mod Pathol 24:899–907. https://doi.org/10.1038/modpathol.2011.47

Article  CAS  PubMed  PubMed Central  Google Scholar 

Janser FA, Adams O, Bütler V, Schläfli AM, Dislich B, Seiler CA, Kröll D, Langer R, Tschan MP (2018) Her2-Targeted therapy induces autophagy in esophageal adenocarcinoma cells. Int J Mol Sci 19. https://doi.org/10.3390/ijms19103069

Jochems SHJ, Fritz J, Häggström C, Stattin P, Stocks T (2023) Prediagnostic markers of insulin resistance and prostate cancer risk and death: a pooled study. Cancer Med 12:13732–13744. https://doi.org/10.1002/cam4.6004

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim YM, Kim J-H, Park JS, Baik SJ, Chun J, Youn YH, Park H (2022) Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study. Gastric Cancer 25:33–41. https://doi.org/10.1007/s10120-021-01222-4

Article  CAS  PubMed  Google Scholar 

Lee J, Chang Y, Kim Y, Park B, Ryu S (2022a) Insulin resistance and the development of breast cancer in premenopausal women: the Kangbuk Samsung Health Study. Breast Cancer Res Treat 192:401–409. https://doi.org/10.1007/s10549-022-06513-7

Article  CAS  PubMed  Google Scholar 

Lee JE, Han K, Yoo J, Yeo Y, Cho IY, Cho B, Park J-H, Shin DW, Cho JH, Park Y-M (2022b) Association between metabolic syndrome and risk of Esophageal Cancer: a Nationwide Population-based study. Cancer Epidemiol Biomarkers Prev 31:2228–2236. https://doi.org/10.1158/1055-9965.EPI-22-0703

Article  CAS  PubMed  Google Scholar 

Lindkvist B, Johansen D, Stocks T, Concin H, Bjørge T, Almquist M, Häggström C, Engeland A, Hallmans G, Nagel G, Jonsson H, Selmer R, Ulmer H, Tretli S, Stattin P, Manjer J (2014) Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project. BMC Cancer 14:103. https://doi.org/10.1186/1471-2407-14-103

Article  CAS  PubMed  PubMed Central  Google Scholar 

Listed NA (2009) Implementation of the International Statistical Classification of Diseases and related health problems, Tenth Revision (ICD-10). Acta Chir Iugosl 56:65–69

Article  Google Scholar 

Liu B, Cheng B, Wang C, Chen P, Cheng Y (2018) The prognostic significance of metabolic syndrome and weight loss in esophageal squamous cell carcinoma. Sci Rep 8:10101. https://doi.org/10.1038/s41598-018-28268-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu T, Zhang Q, Wang Y, Ma X, Zhang Q, Song M, Cao L, Shi H (2022) Association between the TyG index and TG/HDL-C ratio as insulin resistance markers and the risk of colorectal cancer. BMC Cancer 22:1007. https://doi.org/10.1186/s12885-022-10100-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu T, Bai Y, Lin X, Li W, Wang J, Zhang X, Pan H, Bai C, Bai L, Cheng Y, Zhang J, Zhong H, Ba Y, Hu W, Xu R, Guo W, Qin S, Yang N, Lu J, Shitara K, Lei M, Li M, Bao N, Chen T, Shen L (2023a) First-line nivolumab plus chemotherapy vs chemotherapy in patients with advanced gastric, gastroesophageal junction and esophageal adenocarcinoma: CheckMate 649 Chinese subgroup analysis. Int J Cancer 152:749–760. https://doi.org/10.1002/ijc.34296

Article  CAS  PubMed  Google Scholar 

Liu X, Chen L, Hu X (2023b) Hyperinsulinemic-euglycemic clamp in conscious rats based on the tail artery and vein catheterization. Methods Mol Biol 2592:155–161. https://doi.org/10.1007/978-1-0716-2807-2_10

Article  CAS  PubMed  Google Scholar 

Liu J, Wang R, Tan S, Zhao X, Hou A (2024) Association between insulin resistance, metabolic syndrome and its components and lung cancer: a systematic review and meta-analysis. Diabetol Metab Syndr 16:63. https://doi.org/10.1186/s13098-024-01308-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matulewicz N, Karczewska-Kupczewska M (2016) Insulin resistance and chronic inflammation. Postepy Hig Med Dosw (Online) 70:1245–1258

PubMed  Google Scholar 

Morgan E, Soerjomataram I, Rumgay H, Coleman HG, Thrift AP, Vignat J, Laversanne M, Ferlay J, Arnold M (2022) The Global Landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020. Gastroenterology 163:649–658e2. https://doi.org/10.1053/j.gastro.2022.05.054

Article  PubMed  Google Scholar 

O’Riordan JM, Abdel-latif MM, Ravi N, McNamara D, Byrne PJ, McDonald GSA, Keeling PWN, Kelleher D, Reynolds JV (2005) Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Gastroenterol 100:1257–1264. https://doi.org/10.1111/j.1572-0241.2005.41338.x

Article  CAS  PubMed  Google Scholar 

Petermann-Rocha F, Ho FK, Foster H, Boopor J, Parra-Soto S, Gray SR, Mathers JC, Celis-Morales C, Pell JP (2021) Nonlinear associations between cumulative dietary risk factors and Cardiovascular diseases, Cancer, and all-cause mortality: a prospective cohort study from UK Biobank. Mayo Clin Proc 96:2418–2431. https://doi.org/10.1016/j.mayocp.2021.01.036

Article  PubMed  Google Scholar 

Plum PS, Gebauer F, Krämer M, Alakus H, Berlth F, Chon S-H, Schiffmann L, Zander T, Büttner R, Hölscher AH, Bruns CJ, Quaas A, Loeser H (2019) HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma. BMC Cancer 19:38. https://doi.org/10.1186/s12885-018-5242-4